A Powerful Point-of-Sale Partnership that Delivers on the Promise of Affordable Insulin

In March of this year the three largest insulin manufacturers announced a dramatic reduction ...

Five Good Reasons GoodRx Should Be in Your 2024 HCP Media Plan

Like other successful and innovative companies, GoodRx has adapted and evolved to stay relevant, ...

Beyond the Media Buy: Opening the Pandora’s Box of Point-of-Care Program Measurement

As pharma companies began to professionalize their point-of-care (POC) messaging strategies, they moved to ...

Specialty Treatments Require a New Approach to Affordability

As a mission-driven company and digital healthcare leader, GoodRx has helped patients obtain an ...

GoodRx Surpasses $500M in Savings for Americans with Diabetes

First, some good news about diabetes. GoodRx is a leading resource for people with ...

Addressing the Polypharmacy Problem

Many of us have someone in our life—a parent, a spouse, or loved one—who ...

Putting the Patient at the Top of Your Adherence Approach

“People adhere to medicines at a scale that should bewilder everyone in healthcare,” exclaims ...

Two Key Questions About Adherence/Compliance in 2023

PM360 asked experts in helping patients stay on their prescribed therapies about where the ...

12 New Ways Companies Are Helping to Improve Adherence

PM360 asked for companies to send in their latest and best ways to improve ...

Tackling the 3 Leading Causes of Nonadherence: Fear, Cost, and Misunderstanding

Medication nonadherence costs the U.S. pharmaceutical industry an estimated $250 billion annually in potential ...